xanthenes has been researched along with azomycin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baguley, BC; Lash, CJ; Li, AE; Rutland, M; Wilson, WR; Zwi, LJ | 1 |
| Campos Aldrete, ME; Luna, J; Meléndez, E; Meráz-Ríos, MA; Salgado-Zamora, H | 1 |
| Escario, JA; Gómez-Barrio, A; Rolón, M; Vega, C | 1 |
| Chen, Y; Diring, S; Furukawa, S; Kamei, K; Kim, C; Kitagawa, S; Kondo, M; Wang, DO | 1 |
| Ballinger, E; Glasheen, J; Gold, B; Ling, Y; Nathan, C; Quezada, LL; Roberts, J; Somersan-Karakaya, S; Warren, JD; Warrier, T | 1 |
| Battaglia, S; Borroni, E; Cabibbe, AM; Cirillo, DM; Hoffmann, H; Hofmann-Thiel, S; Merker, M; Nedialkova, L; Niemann, S; Schena, E; Trovato, A; Utpatel, C | 1 |
| Bethunaickan, R; Chandramohan, Y; Padmanaban, V; Ranganathan, UD; Swaminathan, S; Tripathy, S | 1 |
7 other study(ies) available for xanthenes and azomycin
| Article | Year |
|---|---|
Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Female; Mice; Mice, Inbred C3H; Nitrogen Mustard Compounds; Nitroimidazoles; Prodrugs; Regional Blood Flow; Serotonin; Tirapazamine; Triazines; Xanthenes; Xanthones | 1998 |
A high-throughput colorimetric and fluorometric microassay for the evaluation of nitroimidazole derivatives anti-trichomonas activity.
Topics: Animals; Antitrichomonal Agents; Biological Assay; Colorimetry; Fluorometry; Indicators and Reagents; Nitroimidazoles; Oxazines; Oxidation-Reduction; Trichomonas vaginalis; Xanthenes | 2005 |
Development of resazurin microtiter assay for drug sensibility testing of Trypanosoma cruzi epimastigotes.
Topics: Animals; Colorimetry; Humans; Indicators and Reagents; Nifurtimox; Nitroimidazoles; Oxazines; Oxidation-Reduction; Parasitic Sensitivity Tests; Sensitivity and Specificity; Trypanocidal Agents; Trypanosoma cruzi; Xanthenes | 2006 |
Localized cell stimulation by nitric oxide using a photoactive porous coordination polymer platform.
Topics: Aniline Compounds; Biocompatible Materials; Calcium; Dimethylpolysiloxanes; Drug Delivery Systems; Fluorescent Dyes; HEK293 Cells; Humans; Light; Microscopy, Fluorescence; Nitric Oxide; Nitroimidazoles; Photochemical Processes; Porosity; Single-Cell Analysis; Xanthenes | 2013 |
Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis.
Topics: Agar; Antitubercular Agents; Biological Assay; Charcoal; Colony Count, Microbial; Coloring Agents; Diarylquinolines; Fluorometry; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazines; Xanthenes | 2015 |
Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system.
Topics: Antitubercular Agents; Automation, Laboratory; Colorimetry; Genes, Bacterial; Indicators and Reagents; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazines; Oxazoles; Polymorphism, Genetic; Sequence Analysis, DNA; Xanthenes | 2016 |
In vitro interaction profiles of the new antitubercular drugs bedaquiline and delamanid with moxifloxacin against clinical Mycobacterium tuberculosis isolates.
Topics: Antitubercular Agents; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Drug Synergism; Extensively Drug-Resistant Tuberculosis; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Nitroimidazoles; Oxazines; Oxazoles; Tuberculosis, Multidrug-Resistant; Xanthenes | 2019 |